Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIME-1: AKB-9778 in Diabetic Macular Edema
NCT01702441Phase 2Completed
- Sponsor
- Aerpio Therapeutics
- Start
- Sep 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of razuprotafib in diabetic macular edema (DME), sponsored by Aerpio Therapeutics. Started Sep 2012; status: completed.
02
Drugs
razuprotafib
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01702441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01702441.